Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	chromatin binding	NCOA2 ERCC3 ERCC6 TOX KDM3B UPF1 CLOCK SETDB1 GTF2F1 PELP1 HOXD10 NFATC2 PKNOX1 NCOA1 ASXL2 KAT6B NFAT5	2.91e-06	739	123	17	GO:0003682
GeneOntologyMolecularFunction	histone modifying activity	ATPSCKMT KDM3B CLOCK RSBN1 KMT2C SETDB1 NCOA1 KAT6B OGA	1.24e-05	229	123	9	GO:0140993
GeneOntologyMolecularFunction	transcription coactivator activity	NCOA2 MED30 MAML1 KMT2C TSC22D1 RBM14 NCOA1 MAML2 TAF5L KAT6B	1.85e-05	303	123	10	GO:0003713
GeneOntologyMolecularFunction	histone acetyltransferase activity	CLOCK NCOA1 KAT6B OGA	2.74e-04	51	123	4	GO:0004402
GeneOntologyMolecularFunction	peptide-lysine-N-acetyltransferase activity	CLOCK NCOA1 KAT6B OGA	3.67e-04	55	123	4	GO:0061733
GeneOntologyMolecularFunction	peptide N-acetyltransferase activity	CLOCK NCOA1 KAT6B OGA	5.12e-04	60	123	4	GO:0034212
GeneOntologyMolecularFunction	nuclear receptor coactivator activity	NCOA2 MED30 RBM14 NCOA1	5.45e-04	61	123	4	GO:0030374
GeneOntologyMolecularFunction	transcription coregulator activity	NCOA2 MED30 MAML1 KDM3B KMT2C TSC22D1 RBM14 NCOA1 MAML2 TAF5L KAT6B	7.15e-04	562	123	11	GO:0003712
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	NCOA2 MED30 HIVEP2 ERCC6 TOX RIPK2 MAML1 WT1 NCK1 CLOCK SLC40A1 KMT2C TSC22D1 GTF2F1 PELP1 HOXD10 NFATC2 LMX1B NFYA RBM14 PKNOX1 NCOA1 RORB ASXL2 MAML2 USF1 KAT6B NFAT5	7.53e-09	1390	122	28	GO:0045944
GeneOntologyCellularComponent	transcription regulator complex	NCOA2 MED30 ERCC3 HIVEP2 CLOCK GTF3C3 GTF2F1 HOXD10 NFATC2 NFYA RBM14 PKNOX1 NCOA1 TAF5L USF1 NFAT5	4.40e-07	596	123	16	GO:0005667
GeneOntologyCellularComponent	RNA polymerase II transcription regulator complex	NCOA2 MED30 ERCC3 CLOCK GTF2F1 NFATC2 NFYA NCOA1 TAF5L	3.38e-05	272	123	9	GO:0090575
GeneOntologyCellularComponent	chromatin	NCOA2 ERCC6 EIF3E HDX KDM3B POU3F4 UPF1 CLOCK PELP1 HOXD10 NFATC2 LMX1B NFYA PKNOX1 NCOA1 RORB TAF5L USF1 KAT6B NFAT5	3.93e-04	1480	123	20	GO:0000785
HumanPheno	Abnormal ankle physiology	COMP POU3F4 SPG11 SLC52A3 SMG9 PYCR2	3.87e-05	72	46	6	HP:0034674
HumanPheno	Abnormality of the ankle	COMP ANO5 POU3F4 SPG11 ADGRV1 SLC52A3 NFATC2 SMG9 PYCR2	4.18e-05	192	46	9	HP:0003028
HumanPheno	Abnormality of the joints of the lower limbs	FLNB FLNC ERCC6 COMP ANO5 POU3F4 SPG11 ADGRV1 SLC52A3 PIEZO2 NFATC2 LMX1B SMG9 PYCR2 KAT6B	5.16e-05	547	46	15	HP:0100239
HumanPheno	Abnormality of the knee	FLNB FLNC ERCC6 COMP ANO5 POU3F4 SPG11 ADGRV1 SLC52A3 PIEZO2 NFATC2 LMX1B SMG9 KAT6B	6.52e-05	491	46	14	HP:0002815
Domain	SUZ	ARPP21 R3HDM2 R3HDM1	1.06e-06	4	121	3	IPR024771
Domain	SUZ	ARPP21 R3HDM2 R3HDM1	1.06e-06	4	121	3	PS51673
Domain	PAS	NCOA2 CLOCK KCNH1 NCOA1	1.91e-05	25	121	4	PF00989
Domain	PAS_fold	NCOA2 CLOCK KCNH1 NCOA1	1.91e-05	25	121	4	IPR013767
Domain	R3H	ARPP21 R3HDM2 R3HDM1	2.17e-05	9	121	3	SM00393
Domain	R3H	ARPP21 R3HDM2 R3HDM1	4.21e-05	11	121	3	PS51061
Domain	R3H	ARPP21 R3HDM2 R3HDM1	4.21e-05	11	121	3	PF01424
Domain	-	ARPP21 R3HDM2 R3HDM1	4.21e-05	11	121	3	3.30.1370.50
Domain	R3H_dom	ARPP21 R3HDM2 R3HDM1	4.21e-05	11	121	3	IPR001374
Domain	PAS	NCOA2 CLOCK KCNH1 NCOA1	5.24e-05	32	121	4	SM00091
Domain	PAS	NCOA2 CLOCK KCNH1 NCOA1	6.69e-05	34	121	4	PS50112
Domain	PAS	NCOA2 CLOCK KCNH1 NCOA1	6.69e-05	34	121	4	IPR000014
Domain	DUF1518	NCOA2 NCOA1	1.24e-04	3	121	2	PF07469
Domain	Nuc_rcpt_coact_Ncoa-typ	NCOA2 NCOA1	1.24e-04	3	121	2	IPR014920
Domain	SRC-1	NCOA2 NCOA1	1.24e-04	3	121	2	IPR014935
Domain	COMP	COMP THBS3	1.24e-04	3	121	2	PF11598
Domain	Src1_rcpt_coact	NCOA2 NCOA1	1.24e-04	3	121	2	IPR008955
Domain	Nuclear_rcpt_coactivator	NCOA2 NCOA1	1.24e-04	3	121	2	IPR017426
Domain	MamL-1	MAML1 MAML2	1.24e-04	3	121	2	SM01275
Domain	-	NCOA2 NCOA1	1.24e-04	3	121	2	4.10.630.10
Domain	Neuroggenic_mastermind-like_N	MAML1 MAML2	1.24e-04	3	121	2	IPR019082
Domain	Thbs/COMP_coiled-coil	COMP THBS3	1.24e-04	3	121	2	IPR024665
Domain	DUF1518	NCOA2 NCOA1	1.24e-04	3	121	2	IPR010011
Domain	SUZ	ARPP21 R3HDM1	1.24e-04	3	121	2	PF12752
Domain	MamL-1	MAML1 MAML2	1.24e-04	3	121	2	PF09596
Domain	DUF1518	NCOA2 NCOA1	1.24e-04	3	121	2	SM01151
Domain	SRC-1	NCOA2 NCOA1	1.24e-04	3	121	2	PF08832
Domain	Nuc_rec_co-act	NCOA2 NCOA1	1.24e-04	3	121	2	PF08815
Domain	TSP_3	COMP THBS3	4.11e-04	5	121	2	PF02412
Domain	TSP3	COMP THBS3	4.11e-04	5	121	2	PS51234
Domain	TSP_CTER	COMP THBS3	4.11e-04	5	121	2	PS51236
Domain	Thrombospondin_3_rpt	COMP THBS3	4.11e-04	5	121	2	IPR017897
Domain	TSP_type-3_rpt	COMP THBS3	4.11e-04	5	121	2	IPR028974
Domain	NFAT	NFATC2 NFAT5	4.11e-04	5	121	2	IPR008366
Domain	PKNOX/Meis_N	PKNOX2 PKNOX1	4.11e-04	5	121	2	IPR032453
Domain	-	COMP THBS3	4.11e-04	5	121	2	4.10.1080.10
Domain	Thrombospondin_C	COMP THBS3	4.11e-04	5	121	2	IPR008859
Domain	TSP_C	COMP THBS3	4.11e-04	5	121	2	PF05735
Domain	Meis_PKNOX_N	PKNOX2 PKNOX1	4.11e-04	5	121	2	PF16493
Domain	Thrombospondin_3-like_rpt	COMP THBS3	4.11e-04	5	121	2	IPR003367
Domain	Nuc_rcpt_coact	NCOA2 NCOA1	6.14e-04	6	121	2	IPR009110
Domain	Rudment_hybrid_motif	ACACA GART	6.14e-04	6	121	2	IPR011054
Domain	PAC	NCOA2 CLOCK KCNH1	6.18e-04	26	121	3	IPR001610
Domain	PAC	NCOA2 CLOCK KCNH1	6.18e-04	26	121	3	SM00086
Domain	EGF	COMP LAMC1 EYS THBS3 MUC17 ASTN1 ADGRE1	8.56e-04	235	121	7	SM00181
Domain	Helicase/UvrB_N	ERCC3 UPF1	1.14e-03	8	121	2	IPR006935
Domain	ResIII	ERCC3 UPF1	1.14e-03	8	121	2	PF04851
Domain	EGF-like_dom	COMP LAMC1 EYS THBS3 MUC17 ASTN1 ADGRE1	1.20e-03	249	121	7	IPR000742
Domain	EGF_1	COMP LAMC1 EYS THBS3 MUC17 ASTN1 ADGRE1	1.37e-03	255	121	7	PS00022
Domain	EGF-like_CS	COMP LAMC1 EYS THBS3 MUC17 ASTN1 ADGRE1	1.57e-03	261	121	7	IPR013032
Domain	EGF_2	COMP LAMC1 EYS THBS3 MUC17 ASTN1 ADGRE1	1.71e-03	265	121	7	PS01186
Domain	RHD_dimer	NFATC2 NFAT5	1.81e-03	10	121	2	IPR032397
Domain	RHD_dimer	NFATC2 NFAT5	1.81e-03	10	121	2	PF16179
Domain	IG_FLMN	FLNB FLNC	1.81e-03	10	121	2	SM00557
Domain	REL_1	NFATC2 NFAT5	1.81e-03	10	121	2	PS01204
Domain	-	NFATC2 NFAT5	1.81e-03	10	121	2	2.60.40.340
Domain	NFkB/Dor	NFATC2 NFAT5	1.81e-03	10	121	2	IPR000451
Domain	RHD_DNA_bind_dom	NFATC2 NFAT5	1.81e-03	10	121	2	IPR011539
Domain	RHD_DNA_bind	NFATC2 NFAT5	1.81e-03	10	121	2	PF00554
Domain	REL_2	NFATC2 NFAT5	1.81e-03	10	121	2	PS50254
Domain	-	CFAP61 KAT6B OGA	2.20e-03	40	121	3	3.40.630.30
Domain	Filamin	FLNB FLNC	2.20e-03	11	121	2	PF00630
Domain	FILAMIN_REPEAT	FLNB FLNC	2.20e-03	11	121	2	PS50194
Domain	Filamin/ABP280_rpt	FLNB FLNC	2.20e-03	11	121	2	IPR001298
Domain	Filamin/ABP280_repeat-like	FLNB FLNC	2.20e-03	11	121	2	IPR017868
Domain	Acyl_CoA_acyltransferase	CFAP61 KAT6B OGA	3.09e-03	45	121	3	IPR016181
Domain	-	ACACA GART	3.10e-03	13	121	2	3.40.50.20
Domain	-	COMP ADGRV1 EYS THBS3	3.39e-03	95	121	4	2.60.120.200
Domain	Growth_fac_rcpt_	COMP LAMC1 EYS THBS3 ADGRE1	3.48e-03	156	121	5	IPR009030
Domain	ATP_GRASP	ACACA GART	3.60e-03	14	121	2	PS50975
Domain	Sugar/inositol_transpt	SLC2A7 SLC2A11	3.60e-03	14	121	2	IPR003663
Domain	SEA	MUC16 MUC17	3.60e-03	14	121	2	SM00200
Domain	ATP-grasp	ACACA GART	3.60e-03	14	121	2	IPR011761
Domain	PreATP-grasp_dom	ACACA GART	3.60e-03	14	121	2	IPR016185
Domain	EGF_Ca-bd_CS	COMP EYS THBS3 ADGRE1	3.65e-03	97	121	4	IPR018097
Domain	EGF_CA	COMP EYS THBS3 ADGRE1	3.93e-03	99	121	4	PS01187
Domain	-	MUC16 MUC17	4.14e-03	15	121	2	3.30.70.960
Domain	-	ACACA GART	4.14e-03	15	121	2	3.30.1490.20
Domain	Homeobox	HDX POU3F4 PKNOX2 HOXD10 LMX1B PKNOX1	4.21e-03	234	121	6	PF00046
Domain	EGF_3	COMP EYS THBS3 MUC17 ASTN1 ADGRE1	4.30e-03	235	121	6	PS50026
Domain	HOMEOBOX_1	HDX POU3F4 PKNOX2 HOXD10 LMX1B PKNOX1	4.39e-03	236	121	6	PS00027
Domain	HOX	HDX POU3F4 PKNOX2 HOXD10 LMX1B PKNOX1	4.48e-03	237	121	6	SM00389
Domain	HOMEOBOX_2	HDX POU3F4 PKNOX2 HOXD10 LMX1B PKNOX1	4.67e-03	239	121	6	PS50071
Domain	Homeobox_dom	HDX POU3F4 PKNOX2 HOXD10 LMX1B PKNOX1	4.67e-03	239	121	6	IPR001356
Domain	Ig_E-set	FLNB FLNC NFATC2 NFAT5	4.68e-03	104	121	4	IPR014756
Domain	Post-SET_dom	KMT2C SETDB1	4.71e-03	16	121	2	IPR003616
Domain	PostSET	KMT2C SETDB1	4.71e-03	16	121	2	SM00508
Domain	POST_SET	KMT2C SETDB1	4.71e-03	16	121	2	PS50868
Domain	Homeobox_KN	PKNOX2 PKNOX1	5.31e-03	17	121	2	PF05920
Domain	Homeobox_KN_domain	PKNOX2 PKNOX1	5.31e-03	17	121	2	IPR008422
Domain	SUGAR_TRANSPORT_2	SLC2A7 SLC2A11	5.31e-03	17	121	2	PS00217
Domain	-	NCOA2 CLOCK NCOA1 USF1	5.53e-03	109	121	4	4.10.280.10
Domain	ATP_grasp_subdomain_1	ACACA GART	5.95e-03	18	121	2	IPR013815
Domain	-	ACACA GART	5.95e-03	18	121	2	3.30.470.20
Pathway	REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF	NCOA2 ACACA SEC24B NFYA NCOA1	3.33e-05	55	95	5	M27001
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	NCOA2 MED30 ERCC3 HIVEP2 HDX MAML1 WT1 POU3F4 CLOCK GTF3C3 PKNOX2 GTF2F1 HOXD10 LMX1B NFYA RBM14 PKNOX1 RORB TAF5L	3.37e-10	877	124	19	20211142
Pubmed	New nomenclature for chromatin-modifying enzymes.	NCOA2 KDM3B CLOCK KMT2C SETDB1 NCOA1 KAT6B	1.41e-09	57	124	7	18022353
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	NCOA2 HIVEP2 TOX WT1 POU3F4 PKNOX2 KMT2C THBS3 HOXD10 NFATC2 PKNOX1 NCOA1 USF1 KAT6B NFAT5	3.86e-08	709	124	15	22988430
Pubmed	Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation.	FLNB ACACA GART EIF3E UPF1 GTF3C3 GLDC RBM14 XRN1 NUP188 PYCR2 OGA PALLD	6.63e-08	534	124	13	35032548
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	NCOA2 HDX MAML1 R3HDM2 PELP1 RBM14 NCOA1 R3HDM1	7.93e-08	152	124	8	38360978
Pubmed	A census of human transcription factors: function, expression and evolution.	HIVEP2 HDX WT1 POU3F4 CLOCK PKNOX2 TSC22D1 HOXD10 NFATC2 LMX1B NFYA PKNOX1 NCOA1 RORB USF1 NFAT5	1.60e-07	908	124	16	19274049
Pubmed	Functional proteomics mapping of a human signaling pathway.	FLNB FLNC ERCC6 EIF3E KDM3B LAMC1 STAM ZZEF1 SETDB1 KIF3B PELP1 ASXL2 PYCR2	2.12e-07	591	124	13	15231748
Pubmed	Global gene expression analysis of murine limb development.	KMT2C HOXD10 LMX1B PKNOX1 USF1 KAT6B NFAT5	2.21e-07	117	124	7	22174793
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TNIK R3HDM2 RSBN1 SETDB1 KIF3B STARD9 NAV3 ASXL2 R3HDM1 NFAT5 PLCE1	2.55e-07	407	124	11	12693553
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	FLNB FLNC EPPK1 ACACA GART EIF3E UPF1 KRR1 GTF3C3 PELP1 NUP210 XRN1 NUP188	6.53e-07	653	124	13	22586326
Pubmed	Dysregulation of ferroportin 1 interferes with spleen organogenesis in polycythaemia mice.	WT1 SLC40A1 ADGRE1	1.53e-06	7	124	3	15342464
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	FLNC EPPK1 HIVEP2 ACACA GRK5 MTMR8 NAGLU MAML1 KDM3B POMGNT1 ZZEF1 SLC52A3 ESRP2 KMT2C LMX1B NUP188	2.11e-06	1105	124	16	35748872
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MAML1 KDM3B SPG11 ADGRV1 ZZEF1 CLOCK KMT2C NUP188 MAML2 KAT6B OGA	3.27e-06	529	124	11	14621295
Pubmed	Human transcription factor protein interaction networks.	NCOA2 EIF3E MAML1 R3HDM2 UPF1 KRR1 GTF3C3 RSBN1 KMT2C SETDB1 SEC24B NFYA XRN1 NCOA1 ASXL2 TAF5L R3HDM1 RAI2	3.30e-06	1429	124	18	35140242
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	NCOA2 FLNC ERCC3 ACACA HDX KDM3B UPF1 STAM SEC24B PALLD	4.64e-06	444	124	10	34795231
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	NCOA2 TOX WT1 KDM3B BTBD9 CLOCK TSC22D1 NFYA PKNOX1 NCOA1 USF1 KAT6B NFAT5	6.70e-06	808	124	13	20412781
Pubmed	The RNA-binding protein ARPP21 controls dendritic branching by functionally opposing the miRNA it hosts.	ARPP21 UPF1 R3HDM1	7.15e-06	11	124	3	29581509
Pubmed	Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry.	TNIK ARPP21 NCK1 NFATC2 RBM14 R3HDM1	8.62e-06	133	124	6	15144186
Pubmed	Agonist-specific Protein Interactomes of Glucocorticoid and Androgen Receptor as Revealed by Proximity Mapping.	NCOA2 NUP210 RBM14 NCOA1 NUP188	9.11e-06	78	124	5	28611094
Pubmed	The expression of Wilms' tumour-1 and Ca125 in invasive micropapillary carcinoma of the breast.	WT1 MUC16	1.26e-05	2	124	2	18042071
Pubmed	Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography.	RNF213 OCLN	1.26e-05	2	124	2	18318008
Pubmed	SRC-1 and TIF2 control energy balance between white and brown adipose tissues.	NCOA2 NCOA1	1.26e-05	2	124	2	12507421
Pubmed	A novel human actin-binding protein homologue that binds to platelet glycoprotein Ibalpha.	FLNB FLNC	1.26e-05	2	124	2	9694715
Pubmed	Partially redundant functions of SRC-1 and TIF2 in postnatal survival and male reproduction.	NCOA2 NCOA1	1.26e-05	2	124	2	15070739
Pubmed	Thyroid function in mice with compound heterozygous and homozygous disruptions of SRC-1 and TIF-2 coactivators: evidence for haploinsufficiency.	NCOA2 NCOA1	1.26e-05	2	124	2	11897715
Pubmed	Distinct steady-state nuclear receptor coregulator complexes exist in vivo.	NCOA2 NCOA1	1.26e-05	2	124	2	9751728
Pubmed	X-ray structure of the orphan nuclear receptor RORbeta ligand-binding domain in the active conformation.	NCOA1 RORB	1.26e-05	2	124	2	11689423
Pubmed	Hepatic SRC-1 activity orchestrates transcriptional circuitries of amino acid pathways with potential relevance for human metabolic pathogenesis.	NCOA2 NCOA1	1.26e-05	2	124	2	25148457
Pubmed	Dysregulation of WTI (-KTS) is Associated with the Kidney-Specific Effects of the LMX1B R246Q Mutation.	WT1 LMX1B	1.26e-05	2	124	2	28059119
Pubmed	The human T-lymphotropic virus type 1 tax protein inhibits nonsense-mediated mRNA decay by interacting with INT6/EIF3E and UPF1.	EIF3E UPF1	1.26e-05	2	124	2	22553336
Pubmed	The limits of promiscuity: isoform-specific dimerization of filamins.	FLNB FLNC	1.26e-05	2	124	2	12525170
Pubmed	Disruption of NCOA2 by recurrent fusion with LACTB2 in colorectal cancer.	NCOA2 LACTB2	1.26e-05	2	124	2	25823027
Pubmed	Replication of results of genome-wide association studies on esophageal squamous cell carcinoma susceptibility loci in a Korean population.	SLC52A3 PLCE1	1.26e-05	2	124	2	24152165
Pubmed	Tumor necrosis factor-alpha suppresses the expression of steroid receptor coactivator-1 and -2: a possible mechanism contributing to changes in steroid hormone responsiveness.	NCOA2 NCOA1	1.26e-05	2	124	2	15231721
Pubmed	Expression of the excision repair gene, ERCC3 (excision repair cross-complementing), during mouse development.	ERCC3 WT1	1.26e-05	2	124	2	7805288
Pubmed	Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54.	SLC52A3 PLCE1	1.26e-05	2	124	2	20729853
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	TNIK EIF3E MAML1 KDM3B RNF213 SPG11 NCK1 SETDB1 GTF2F1 XRN1 SMG9 R3HDM1	1.30e-05	733	124	12	34672954
Pubmed	Activating signal cointegrator 2 belongs to a novel steady-state complex that contains a subset of trithorax group proteins.	NCOA2 KMT2C NCOA1	1.56e-05	14	124	3	12482968
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	TNIK TOX KDM3B ADGRV1 KMT2C KAT6B OGA	1.71e-05	225	124	7	12168954
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	EPPK1 ACACA SLC2A7 GART EIF3E UPF1 MMP24 NUP210 SEC24B ASTN1 OGA GOLGA3	1.72e-05	754	124	12	35906200
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	FLNB ACACA GART EIF3E UPF1 GTF3C3 PELP1 NUP210 RBM14 NUP188 PYCR2	1.89e-05	638	124	11	33239621
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	ACACA COMP SPG11 UPF1 MSTO1 KMT2C PELP1 PIK3CB XRN1 SMG9 NCOA1 NUP188 MAML2 TAF5L R3HDM1 OGA	2.08e-05	1327	124	16	32694731
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	ACACA MAML1 KDM3B ARFGEF1 MUC16 RNF213 GTF3C3 SEC24B RBM14 XRN1 OCLN GOLGA3	2.31e-05	777	124	12	35844135
Pubmed	Impact of cytosine methylation on DNA binding specificities of human transcription factors.	POU3F4 CLOCK PKNOX2 HOXD10 NFATC2 LMX1B PKNOX1 RORB USF1 NFAT5	2.68e-05	544	124	10	28473536
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	NCOA2 ACACA KDM3B NCK1 UPF1 GTF3C3 KMT2C SEC24B XRN1 PALLD	2.89e-05	549	124	10	38280479
Pubmed	Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.	FLNB FLNC GART EIF3E HDX UPF1 KRR1 ACAD11 RBM14 GOLGA3	2.98e-05	551	124	10	34728620
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	ERCC3 ACACA UPF1 GTF3C3 SETDB1 PELP1 NUP210 SMG9 NUP188	3.01e-05	440	124	9	34244565
Pubmed	The RNA helicase DHX34 activates NMD by promoting a transition from the surveillance to the decay-inducing complex.	UPF1 XRN1 SMG9	3.47e-05	18	124	3	25220460
Pubmed	Identification of new human mastermind proteins defines a family that consists of positive regulators for notch signaling.	MAML1 MAML2	3.77e-05	3	124	2	12386158
Pubmed	Functional characterization of the native NH2-terminal transactivation domain of the human androgen receptor: binding kinetics for interactions with TFIIF and SRC-1a.	GTF2F1 NCOA1	3.77e-05	3	124	2	18284209
Pubmed	Steroid receptor coactivator 2 is critical for progesterone-dependent uterine function and mammary morphogenesis in the mouse.	NCOA2 NCOA1	3.77e-05	3	124	2	16914740
Pubmed	Ferroportin1 deficiency in mouse macrophages impairs iron homeostasis and inflammatory responses.	SLC40A1 ADGRE1	3.77e-05	3	124	2	21705499
Pubmed	Absence of the steroid receptor coactivator-3 induces B-cell lymphoma.	NCOA2 NCOA1	3.77e-05	3	124	2	16675958
Pubmed	Pathological Significance and Prognostic Roles of Thrombospondin-3, 4 and 5 in Bladder Cancer.	COMP THBS3	3.77e-05	3	124	2	33910854
Pubmed	Steroid receptor coactivator 2 is essential for progesterone-dependent uterine function and mammary morphogenesis: insights from the mouse--implications for the human.	NCOA2 NCOA1	3.77e-05	3	124	2	17045797
Pubmed	Prep2: cloning and expression of a new prep family member.	PKNOX2 PKNOX1	3.77e-05	3	124	2	12412021
Pubmed	Recurrent MEIS1-NCOA2/1 fusions in a subset of low-grade spindle cell sarcomas frequently involving the genitourinary and gynecologic tracts.	NCOA2 NCOA1	3.77e-05	3	124	2	33574497
Pubmed	The function of TIF2/GRIP1 in mouse reproduction is distinct from those of SRC-1 and p/CIP.	NCOA2 NCOA1	3.77e-05	3	124	2	12138202
Pubmed	The E3 ubiquitin ligase MARCH3 controls the endothelial barrier.	MARCHF3 OCLN	3.77e-05	3	124	2	27616439
Pubmed	Filamin A and Filamin B are co-expressed within neurons during periods of neuronal migration and can physically interact.	FLNB FLNC	3.77e-05	3	124	2	12393796
Pubmed	SRC-2 is an essential coactivator for orchestrating metabolism and circadian rhythm.	NCOA2 CLOCK	3.77e-05	3	124	2	24529706
Pubmed	Inhibitory cross-talk between estrogen receptor (ER) and constitutively activated androstane receptor (CAR). CAR inhibits ER-mediated signaling pathway by squelching p160 coactivators.	NCOA2 NCOA1	3.77e-05	3	124	2	12114525
Pubmed	Expression and clinical significance of IL7R, NFATc2, and RNF213 in familial and sporadic multiple sclerosis.	RNF213 NFATC2	3.77e-05	3	124	2	34584155
Pubmed	Roles of steroid receptor coactivator (SRC)-1 and transcriptional intermediary factor (TIF) 2 in androgen receptor activity in mice.	NCOA2 NCOA1	3.77e-05	3	124	2	15983373
Pubmed	Genomic structure and fine mapping of the two human filamin gene paralogues FLNB and FLNC and comparative analysis of the filamin gene family.	FLNB FLNC	3.77e-05	3	124	2	11153914
Pubmed	The transcriptional coregulators TIF2 and SRC-1 regulate energy homeostasis by modulating mitochondrial respiration in skeletal muscles.	NCOA2 NCOA1	3.77e-05	3	124	2	21035760
Pubmed	Filamins as integrators of cell mechanics and signalling.	FLNB FLNC	3.77e-05	3	124	2	11252955
Pubmed	Thyroid hormone signaling in vivo requires a balance between coactivators and corepressors.	NCOA2 NCOA1	3.77e-05	3	124	2	24550004
Pubmed	Distinctive functions of p160 steroid receptor coactivators in proliferation of an estrogen-independent, tamoxifen-resistant breast cancer cell line.	NCOA2 NCOA1	3.77e-05	3	124	2	21059860
Pubmed	RORgammat recruits steroid receptor coactivators to ensure thymocyte survival.	NCOA2 NCOA1	3.77e-05	3	124	2	16148126
Pubmed	Prognostic value of novel biomarkers in astrocytic brain tumors: nuclear receptor co-regulators AIB1, TIF2, and PELP1 are associated with high tumor grade and worse patient prognosis.	NCOA2 PELP1	3.77e-05	3	124	2	21735116
Pubmed	Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene.	NCOA2 NCOA1	3.77e-05	3	124	2	9506940
Pubmed	Steroid receptor coactivators present a unique opportunity for drug development in hormone-dependent cancers.	NCOA2 NCOA1	3.77e-05	3	124	2	28390937
Pubmed	The role of SRC1 and SRC2 in steroid-induced SDF1 expression in normal and ectopic endometrium.	NCOA2 NCOA1	3.77e-05	3	124	2	24586072
Pubmed	Research resource: loss of the steroid receptor coactivators confers neurobehavioral consequences.	NCOA2 NCOA1	3.77e-05	3	124	2	23927929
Pubmed	An Association and Meta-Analysis of Esophageal Squamous Cell Carcinoma Risk Associated with PLCE1 rs2274223, C20orf54 rs13042395 and RUNX1 rs2014300 Polymorphisms.	SLC52A3 PLCE1	3.77e-05	3	124	2	30666517
Pubmed	Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder.	NCOA2 NCOA1	3.77e-05	3	124	2	18845648
Pubmed	Mutations in PLCE1 are a major cause of isolated diffuse mesangial sclerosis (IDMS).	WT1 PLCE1	3.77e-05	3	124	2	18065803
Pubmed	Structure of the NCoA-1/SRC-1 PAS-B domain bound to the LXXLL motif of the STAT6 transactivation domain.	NCOA2 NCOA1	3.77e-05	3	124	2	14757047
Pubmed	Structure and chromosomal locations of mouse steroid receptor coactivator gene family.	NCOA2 NCOA1	3.77e-05	3	124	2	10501088
Pubmed	Cockayne syndrome group B deficiency reduces H3K9me3 chromatin remodeler SETDB1 and exacerbates cellular aging.	ERCC6 SETDB1	3.77e-05	3	124	2	31276581
Pubmed	The genomic analysis of the impact of steroid receptor coactivators ablation on hepatic metabolism.	NCOA2 NCOA1	3.77e-05	3	124	2	16423883
Pubmed	Proteomic analysis of integrin-associated complexes identifies RCC2 as a dual regulator of Rac1 and Arf6.	FLNB FLNC ACACA GART EIF3E UPF1 PELP1 NUP210 RBM14 NUP188 PYCR2	4.80e-05	707	124	11	19738201
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	NCOA2 FLNB HIVEP2 NCK1 STAM RPH3A MSTO1 SETDB1 NAV3 PKNOX1 TOLLIP ASTN1 RORB R3HDM1 GOLGA3	5.54e-05	1285	124	15	35914814
Pubmed	Toward understanding the genetics of alcohol drinking through transcriptome meta-analysis.	NMNAT3 PKNOX2 ACAD11	5.61e-05	21	124	3	16618939
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	HIVEP2 ACACA RIPK2 KDM3B LAMC1 VPS13D STARD9 SEC24B RBM14 XRN1 R3HDM1 PALLD	6.20e-05	861	124	12	36931259
Pubmed	AMPK, a Regulator of Metabolism and Autophagy, Is Activated by Lysosomal Damage via a Novel Galectin-Directed Ubiquitin Signal Transduction System.	FLNB FLNC ACACA GART EIF3E UPF1 SEC24B NUP188 OCLN	6.28e-05	484	124	9	31995728
Pubmed	A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart.	FLNC ANO5 R3HDM1 NFAT5	6.43e-05	60	124	4	19075228
Pubmed	Fine expression profiling of full-length transcripts using a size-unbiased cDNA library prepared with the vector-capping method.	FLNB FLNC ACACA	6.48e-05	22	124	3	18487259
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	ACACA R3HDM2 BEND2 SETDB1 RBM14 TOLLIP R3HDM1 PYCR2 KAT6B RAI2	6.79e-05	608	124	10	16713569
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	FLNB MAGEB4 ACACA CDKL2 NAGLU RNF213 C11orf24 ZZEF1 ESRP2 KMT2C NUP188	6.87e-05	736	124	11	29676528
Pubmed	CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.	FLNB FLNC GART EIF3E ARFGEF1 UPF1 SEC24B RBM14 PALLD	7.33e-05	494	124	9	26831064
Pubmed	Multiple signal input and output domains of the 160-kilodalton nuclear receptor coactivator proteins.	NCOA2 NCOA1	7.53e-05	4	124	2	10454563
Pubmed	The SH2-containing inositol polyphosphate 5-phosphatase, SHIP-2, binds filamin and regulates submembraneous actin.	FLNB FLNC	7.53e-05	4	124	2	11739414
Pubmed	Expressions of tight junction proteins Occludin and Claudin-1 are under the circadian control in the mouse large intestine: implications in intestinal permeability and susceptibility to colitis.	CLOCK OCLN	7.53e-05	4	124	2	24845399
Pubmed	Structural interaction and functional regulation of polycystin-2 by filamin.	FLNB FLNC	7.53e-05	4	124	2	22802962
Pubmed	Recruitment of the NCoA/SRC-1/p160 family of transcriptional coactivators by the aryl hydrocarbon receptor/aryl hydrocarbon receptor nuclear translocator complex.	NCOA2 NCOA1	7.53e-05	4	124	2	12024042
Pubmed	Structure-dependent activity of glycyrrhetinic acid derivatives as peroxisome proliferator-activated receptor {gamma} agonists in colon cancer cells.	NCOA2 NCOA1	7.53e-05	4	124	2	17513608
Pubmed	Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1alpha.	NCOA2 NCOA1	7.53e-05	4	124	2	10594042
Pubmed	Transcriptional synergism on the pS2 gene promoter between a p160 coactivator and estrogen receptor-alpha depends on the coactivator subtype, the type of estrogen response element, and the promoter context.	NCOA2 NCOA1	7.53e-05	4	124	2	12403846
Interaction	EYA4 interactions	NCOA2 ERCC6 HDX MAML1 R3HDM2 PELP1 SEC24B RBM14 NCOA1 R3HDM1	2.46e-06	243	123	10	int:EYA4
Interaction	CREBBP interactions	NCOA2 ERCC3 HIVEP2 MAML1 WT1 KDM3B CLOCK SETDB1 GTF2F1 PELP1 HOXD10 NFATC2 NFYA NCOA1 MAML2	3.80e-06	599	123	15	int:CREBBP
Interaction	ZC3H7A interactions	GART R3HDM2 SPG11 UPF1 BTBD9 UCP3 XRN1 SMG9 R3HDM1	6.96e-06	215	123	9	int:ZC3H7A
Interaction	PML interactions	NCOA2 FLNC ERCC3 ERCC6 ACACA EIF3E HDX KDM3B RNF213 UPF1 STAM DSN1 GTF3C3 SETDB1 PELP1 SEC24B USF1 PALLD	1.44e-05	933	123	18	int:PML
Interaction	TOP3B interactions	FLNC EPPK1 HIVEP2 ACACA GRK5 MTMR8 NAGLU MAML1 KDM3B POMGNT1 R3HDM2 UPF1 ZZEF1 SLC52A3 ESRP2 KMT2C PELP1 LMX1B SEC24B RBM14 XRN1 NUP188 OGA	2.50e-05	1470	123	23	int:TOP3B
Interaction	EP300 interactions	NCOA2 ACACA GART EIF3E MAML1 UPF1 KRR1 CLOCK GTF3C3 MSTO1 RSBN1 PELP1 HOXD10 NFATC2 SEC24B NFYA RBM14 NCOA1 MAML2 USF1 PYCR2 PALLD	3.66e-05	1401	123	22	int:EP300
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	NCOA2 CLOCK NCOA1 KAT6B	7.31e-07	17	78	4	486
GeneFamily	General transcription factors\|Xeroderma pigmentosum complementation groups\|DNA helicases\|ERCC excision repair associated	ERCC3 GTF3C3 GTF2F1	1.66e-04	25	78	3	565
GeneFamily	Nuclear factors of activated T-cells	NFATC2 NFAT5	1.82e-04	5	78	2	665
GeneFamily	WD repeat domain containing\|ERCC excision repair associated	ERCC3 ERCC6	3.80e-04	7	78	2	1268
GeneFamily	Basic helix-loop-helix proteins	NCOA2 CLOCK NCOA1 USF1	1.31e-03	110	78	4	420
GeneFamily	CD molecules\|Mucins	MUC16 MUC17	3.66e-03	21	78	2	648
GeneFamily	POU class homeoboxes and pseudogenes	HDX POU3F4	4.38e-03	23	78	2	523
GeneFamily	TALE class homeoboxes and pseudogenes	PKNOX2 PKNOX1	5.58e-03	26	78	2	526
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	NCOA2 FLNB HIVEP2 GRK5 KDM3B ARFGEF1 LAMC1 R3HDM2 SPG11 NCK1 STAM ZZEF1 CLOCK RSBN1 SETDB1 SEC24B NAV3 NCOA1 R3HDM1 KAT6B PLCE1	4.45e-10	856	122	21	M4500
Coexpression	GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN	HIVEP2 KDM3B R3HDM2 SPG11 ASXL2 R3HDM1 KAT6B	9.10e-06	157	122	7	M7733
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	FLNB HIVEP2 ARFGEF1 R3HDM2 NCK1 STAM CLOCK SEC24B NCOA1 R3HDM1 KAT6B	1.19e-05	466	122	11	M13522
Coexpression	GSE21033_3H_VS_12H_POLYIC_STIM_DC_UP	FLNB HDX TSC22D1 GTF2F1 SEC24B ADGRE1 PYCR2	1.31e-05	166	122	7	M7730
Coexpression	GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_DN	CDKL2 RIPK2 C11orf24 MMP24 PIK3CB NCOA1 R3HDM1	4.06e-05	198	122	7	M5013
Coexpression	GSE13306_TREG_VS_TCONV_SPLEEN_UP	HIVEP2 RIPK2 LAMC1 TSC22D1 KIF3B NFATC2 STARD9	4.33e-05	200	122	7	M3224
Coexpression	GSE17721_LPS_VS_CPG_16H_BMDC_DN	ACACA GRK5 TM7SF3 HOXD10 NUP210 ADGRE1 UEVLD	4.33e-05	200	122	7	M4009
Coexpression	CAIRO_HEPATOBLASTOMA_UP	ACACA KDM3B LAMC1 PLPPR1 PIEZO2 R3HDM1 PALLD	6.44e-05	213	122	7	M14601
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GABRG3 GRK5 WT1 PKNOX2 PIEZO2 NFATC2 RORB PALLD	6.58e-08	191	124	8	1caf726bd07fdca389e678fc16304a6ef1790423
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GABRG3 GRK5 WT1 PKNOX2 PIEZO2 NFATC2 RORB PALLD	6.58e-08	191	124	8	3d60c46bced2984c27a1fcf2910bc38b31fb0148
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GABRG3 GRK5 WT1 PKNOX2 PIEZO2 NFATC2 RORB PALLD	6.86e-08	192	124	8	4022f208eb5db760abd0aac782a25e8ab63efc64
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GABRG3 GRK5 WT1 PKNOX2 PIEZO2 NFATC2 RORB PALLD	6.86e-08	192	124	8	9333aba0d04203ccccad78d82bf6359922f810a7
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	NCOA2 ATP13A4 ACACA TOX ADGRV1 BTBD9 NCOA1 MAML2	8.04e-08	196	124	8	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	NCOA2 ATP13A4 ACACA TOX ADGRV1 BTBD9 NCOA1 MAML2	8.69e-08	198	124	8	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GABRG3 GRK5 PIEZO2 NFATC2 STARD9 RORB PALLD	7.41e-07	180	124	7	280ff5c8f292be1b88120db5ff1788b750644856
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GABRG3 GRK5 PIEZO2 NFATC2 STARD9 RORB PALLD	7.41e-07	180	124	7	fdbd7c22044d9328a1e06e2f9a4451529d1df767
ToppCell	-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	FLNC MAML1 WT1 PIEZO2 ST8SIA6 NFATC2 ASTN1	7.69e-07	181	124	7	ef579e958f334da0f9415aa7e3d5c02c807954a6
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TNIK ATP13A4 ACACA TOX CDKL2 ADGRV1 PLPPR1	8.28e-07	183	124	7	6847c1252d6bb105524f812658112517fd351eab
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP13A4 ANO5 ADGRV1 PIEZO2 NAV3 SPAG17 PLCE1	8.58e-07	184	124	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP13A4 ANO5 ADGRV1 PIEZO2 NAV3 SPAG17 PLCE1	8.58e-07	184	124	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP13A4 ANO5 ADGRV1 PIEZO2 NAV3 SPAG17 PLCE1	8.58e-07	184	124	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D175\|Adult / Lineage, Cell type, age group and donor	ATP13A4 EPPK1 ACACA TOX GART BTBD9 PLPPR1	9.91e-07	188	124	7	ec38def1fdbb34ed9b30244806975bd5a4370164
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	TNIK ARFGEF1 RNF213 BTBD9 KMT2C RBM14 MAML2	1.14e-06	192	124	7	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TNIK GABRG3 PKNOX2 PIEZO2 NAV3 PALLD PLCE1	1.22e-06	194	124	7	35f132cc38ac133be01834ed0946188aa0757eb4
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-naive_thymus-derived_CD8-positive,_alpha-beta_T_cell\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	TOX GRK5 MUC16 NFATC2 RORB ASXL2	2.28e-06	136	124	6	9d7080f695de4ef183e3dbdc18ba464a3b8e3469
ToppCell	PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLNC COMP HOXD10 NFAT5 GPRC5B PLCE1	6.24e-06	162	124	6	96c6e94a10b124a1d25dcd705ec5aaa8609c1089
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L4\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ARPP21 R3HDM2 KCNH1 NECTIN1 RORB R3HDM1	6.47e-06	163	124	6	1e8ab00ecc2d2ba35aa6745c0ed38663e26312e8
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L4-L4_IT_VISp_Rspo1\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ARPP21 R3HDM2 KCNH1 NECTIN1 RORB R3HDM1	6.47e-06	163	124	6	431221a41d396b09170476179590eaf8a55266d8
ToppCell	PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COMP HOXD10 NAV3 ASTN1 GPRC5B PLCE1	6.94e-06	165	124	6	347b59aa625a8a960828b8620824d8ac48990e07
ToppCell	PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COMP HOXD10 NAV3 ASTN1 GPRC5B PLCE1	6.94e-06	165	124	6	507c89ece0a336b8e9c65b79889a714e17ddca27
ToppCell	PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COMP HOXD10 NAV3 ASTN1 GPRC5B PLCE1	6.94e-06	165	124	6	39a25be081a5d59c7cf107a997d352793d5025fb
ToppCell	PND03-Endothelial-Endothelial_lymphatic\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COMP HOXD10 NAV3 ASTN1 GPRC5B PLCE1	6.94e-06	165	124	6	1890f9c33b0c5b381d57f97042da2610a093a6de
ToppCell	3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EMILIN2 ANO5 SPG11 ASXL2 MAML2 ADGRE1	1.00e-05	176	124	6	76fdf211bce101e83a27d822cb399487bd107027
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ATP13A4 ACACA ADGRV1 BTBD9 EYS OCLN	1.00e-05	176	124	6	3bbac5c2397535631fce8fa98f6ddb4fe0260351
ToppCell	droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLNB WT1 RPH3A THBS3 RORB GPRC5B	1.14e-05	180	124	6	c4068fe47408cfd899131a85fa4b7e5908926f94
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2\|TCGA-Skin / Sample_Type by Project: Shred V9	CDKL2 TM7SF3 STAM ST8SIA6 PIK3CB KCNH1	1.18e-05	181	124	6	9d5b331cabc5524f0a9fd8b571e87be4c447c7d4
ToppCell	P03-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COMP HOXD10 ASTN1 NFAT5 GPRC5B PLCE1	1.25e-05	183	124	6	89727b4f65949ed2dce9d2e0228c79fe4280230c
ToppCell	P03-Endothelial-lymphatic_endothelial_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COMP HOXD10 ASTN1 NFAT5 GPRC5B PLCE1	1.25e-05	183	124	6	113e6d8d4bb271be984af06cd6c22b180425dcfc
ToppCell	AT1-AT2_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	FLNB ATP13A4 GRK5 MMP24 RAI2 PLCE1	1.25e-05	183	124	6	6821dca076318115d360ff426eb1218cfe104063
ToppCell	Endothelial-B-Donor_07\|World / lung cells shred on cell class, cell subclass, sample id	FLNB FLNC PIEZO2 GLDC MARCHF3 GPRC5B	1.33e-05	185	124	6	133c9dc64d564dae4aeeeca22f386aa3f13fa980
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MUC16 ADGRV1 KMT2C ASTN1 RORB SPAG17	1.37e-05	186	124	6	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	TNIK NCOA2 VPS13D ASXL2 NFAT5 UEVLD	1.37e-05	186	124	6	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ATP13A4 TOX CDKL2 ADGRV1 BTBD9 OCLN	1.41e-05	187	124	6	5df9e1f5ca32217af255e76e6fb5afa346337811
ToppCell	human_hepatoblastoma-Tumor_cells-T2\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	FLNB R3HDM2 PLPPR1 NFATC2 GLDC TBCK	1.41e-05	187	124	6	f3e37c18ac6471c7992609bbddfa4975571c815c
ToppCell	droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLNC COMP HOXD10 NAV3 GPRC5B PLCE1	1.55e-05	190	124	6	e80d66ba0d5c263e94c1ab0b89d1dc7b837af3e1
ToppCell	droplet-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLNC COMP HOXD10 NAV3 GPRC5B PLCE1	1.55e-05	190	124	6	f32d66c0e74e0a2a23ecb857c4daf0d8573a806c
ToppCell	droplet-Lung-18m-Endothelial-lymphatic_endothelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLNC COMP HOXD10 NAV3 GPRC5B PLCE1	1.55e-05	190	124	6	b79ffd05806244a9790cd04c66fb4f92c824e69f
ToppCell	PCW_13-14\|World / Celltypes from embryonic and fetal-stage human lung	TNIK GRK5 SLC40A1 PIEZO2 NCOA1 OGA	1.55e-05	190	124	6	62a3ec1ae0829602b0569cc051210551644f1d46
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	FLNC WT1 MARCHF3 NAV3 ASTN1 PLCE1	1.55e-05	190	124	6	4f775ee24b14733f06ae40b45f2dc1a0f0df0705
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TNIK ATP13A4 ACACA TOX CDKL2 ADGRV1	1.59e-05	191	124	6	a0332a4ef629510fb313ec119195c44a3f704a80
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	ATP13A4 ACACA TOX ADGRV1 BTBD9 OCLN	1.64e-05	192	124	6	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	POU3F4 C4orf54 SLC52A3 TSC22D1 GLDC GPRC5B	1.64e-05	192	124	6	d5ec4cdb15620a5abfc83577353501186c2bc86a
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ATP13A4 TOX CDKL2 ADGRV1 BTBD9 PLPPR1	1.64e-05	192	124	6	fb2f0e897228f808d9ff734ad05e9b49dc38fa50
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TNIK ACACA TOX CDKL2 ADGRV1 BTBD9	1.69e-05	193	124	6	fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf
ToppCell	droplet-Heart-HEART-1m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNC COMP HOXD10 MAML2 OCLN RAI2	1.69e-05	193	124	6	d0a5f212f8e8a13dbbe3e41df92548ef82eef70b
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	GRK5 LAMC1 PKNOX2 PIEZO2 NAV3 PALLD	1.69e-05	193	124	6	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ADGRV1 PLPPR1 ESRP2 GLDC NUP210 OCLN	1.69e-05	193	124	6	ab78fb1603ea6f720ba2d30148fe65dccf271fe1
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TNIK ACACA TOX CDKL2 ADGRV1 BTBD9	1.69e-05	193	124	6	f3cc7cfdbc164a4ed42f87647111522b7d393bcb
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	GRK5 LAMC1 PKNOX2 PIEZO2 NAV3 PALLD	1.74e-05	194	124	6	e93de9428c986b8943fc169258847c650cfab0e5
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TOX POU3F4 STAM C4orf54 SLC52A3 HOXD10	1.74e-05	194	124	6	d602a0cdb69cd5a3e9ef61ddbab8d920557dd73e
ToppCell	PCW_05-06-Epithelial-Epithelial_alveolar-distal\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ADGRV1 PLPPR1 ESRP2 GLDC NUP210 OCLN	1.74e-05	194	124	6	acd5ba9a097595d4caab4f05440531c65a4aa7bc
ToppCell	PCW_05-06-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	EPPK1 ADGRV1 PLPPR1 ESRP2 GLDC NUP210	1.79e-05	195	124	6	b78db0d929be6b04055805ea5ffecc56c47ba956
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell\|Adult / Lineage, Cell type, age group and donor	LAMC1 SLC40A1 PKNOX2 PIEZO2 NAV3 PALLD	1.79e-05	195	124	6	61c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	LAMC1 SLC40A1 PKNOX2 PIEZO2 NAV3 PALLD	1.79e-05	195	124	6	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D122\|Adult / Lineage, Cell type, age group and donor	LAMC1 SLC40A1 PKNOX2 PIEZO2 NAV3 PALLD	1.79e-05	195	124	6	aa0add081881d349099d12efca5cdee098038d4e
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	TNIK GABRG3 EIF3E SLC40A1 PIEZO2 MAML2	1.85e-05	196	124	6	1450cb69c5bf469e97c03bf1890f6f7c54165b8a
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	GRK5 LAMC1 PKNOX2 PIEZO2 NAV3 PALLD	1.85e-05	196	124	6	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	PCW_10-12\|World / Celltypes from embryonic and fetal-stage human lung	TNIK GABRG3 HIVEP2 SLC40A1 NCOA1 NFAT5	1.90e-05	197	124	6	47fd8b0d596c5db1a722473c8efbb17a6bbe7538
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	WT1 SLC40A1 THBS3 PIEZO2 NAV3 ASTN1	1.90e-05	197	124	6	6b6440f1baad5680cf9e13ca3ab72a2c65523d59
ToppCell	Fibroblasts-DKK3+_Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	FLNC COMP LAMC1 THBS3 PIEZO2 PALLD	1.95e-05	198	124	6	4f4632f26a2043c5e4ab89031b4229b5dca1bd48
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TNIK ATP13A4 ACACA TOX CDKL2 ADGRV1	1.95e-05	198	124	6	f948391296c261c473d339069a6d0f20ccd6f38f
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	TNIK GABRG3 EIF3E SLC40A1 PIEZO2 MAML2	1.95e-05	198	124	6	17dc055e2a289496d9c5cdbf3297bdf906dc6d22
ToppCell	Parenchymal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ATP13A4 ACACA TOX ADGRV1 BTBD9 OCLN	2.01e-05	199	124	6	5cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	NCOA2 ACACA BTBD9 KMT2C NCOA1 MAML2	2.01e-05	199	124	6	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Sema3c\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TOX EMILIN2 ANO5 PLPPR1 NFATC2	7.36e-05	155	124	5	5c7b68b59244525e3714806c205a57a2daebf423
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TOX BEND2 SLC52A3 GLDC GPRC5B	8.30e-05	159	124	5	50d951cf27a571c0c5002003c16fbc370fa17eb1
ToppCell	PND07-Endothelial-Endothelial_lymphatic\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLNC COMP HOXD10 NFAT5 PLCE1	8.81e-05	161	124	5	133b4fadb499e842c19f573f9cf09ce08c1d4813
ToppCell	PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLNC COMP HOXD10 NFAT5 PLCE1	8.81e-05	161	124	5	9466b8658244116f8d21f2f88fb8c2d184b1bdf2
ToppCell	PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLNC COMP HOXD10 NFAT5 PLCE1	8.81e-05	161	124	5	cb177ca10d848d0e25399ab5ebfcde1071fb94c2
ToppCell	P07-Endothelial-lymphatic_endothelial_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COMP RPH3A HOXD10 GPRC5B PLCE1	9.33e-05	163	124	5	5cbab3d03bb1af9391ecad635d6eea1dd42c1337
ToppCell	P07-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COMP RPH3A HOXD10 GPRC5B PLCE1	9.33e-05	163	124	5	322ba94c3ec1e1859c2e2195ecb3f7dab8d190f6
ToppCell	PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ADGRV1 PLPPR1 ESRP2 GLDC OCLN	1.05e-04	167	124	5	25af48c640e67848594f5902867ba325fc105da4
ToppCell	TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2\|TCGA-Bile_Duct / Sample_Type by Project: Shred V9	COMP EIF3E NCK1 KIF3B MAML2	1.08e-04	168	124	5	c70bf73bb800e4722cedc35bbc17ea3113d1012d
ToppCell	droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLNB HIVEP2 ST8SIA6 NFATC2 NECTIN1	1.08e-04	168	124	5	99148986aa5628f67d85258c171b254be77a071c
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ERCC6 ST8SIA6 TBCK PALLD RAI2	1.08e-04	168	124	5	94cded2e953c0970bf2f3dbe0ce46bd77a5ed8c7
ToppCell	facs-Heart-RA-18m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNB COMP GLDC MARCHF3 OCLN	1.08e-04	168	124	5	06dc5b2d356d3a9454b10bba6f3b9ead2a0a7d46
ToppCell	facs-Heart-RA-18m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNB COMP GLDC MARCHF3 OCLN	1.08e-04	168	124	5	1002f058a340763e3d8de0bd1f0547a903526ec6
ToppCell	COVID-19-Heart-CM_+_Macrophage\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FLNC ANO5 C4orf54 CFAP61 PALLD	1.14e-04	170	124	5	3f15242a1d3e4e9871d9170b2ef05842fb609c29
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic-Mast_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TNIK EMILIN2 ST8SIA6 NFATC2 MARCHF3	1.17e-04	171	124	5	ac37c80c832504986c7a201d84f4b6aff5e5f323
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TNIK EMILIN2 ST8SIA6 NFATC2 MARCHF3	1.17e-04	171	124	5	b6502a81df4f25660f3ae4b7443a1d999df2d32b
ToppCell	droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLNB HIVEP2 ST8SIA6 NFATC2 NECTIN1	1.17e-04	171	124	5	38a05b5ec8ef8f09a2399994c6b4b9a707918ec1
ToppCell	TCGA-Brain-Primary_Tumor\|TCGA-Brain / Sample_Type by Project: Shred V9	ATP13A4 POU3F4 SLC52A3 GLDC MAML2	1.23e-04	173	124	5	f6ba22661e67c17d49d1058d4170ba8f36bf47f0
ToppCell	BAL-Mild-Epithelial-Epithelial-AT1/AT2\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KCNH1 NAV3 ASTN1 RAI2 GPRC5B	1.27e-04	174	124	5	b7f5492ce8098f7eb0aef30ee558d00738d59d0e
ToppCell	BAL-Mild-Epithelial-Epithelial-AT1/AT2-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	KCNH1 NAV3 ASTN1 RAI2 GPRC5B	1.27e-04	174	124	5	71730503be3d9c839c4c9e950145e2101d682a1c
ToppCell	BAL-Mild-Epithelial-Epithelial-AT1/AT2\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	KCNH1 NAV3 ASTN1 RAI2 GPRC5B	1.27e-04	174	124	5	ee8ac51fa0b426ad7b7453371bb79c8bf8c1d358
ToppCell	BAL-Mild-Epithelial-Epithelial-AT1/AT2-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KCNH1 NAV3 ASTN1 RAI2 GPRC5B	1.27e-04	174	124	5	cafe4d6b5f08d8888e9db6e196c66df991c03e7b
ToppCell	P15-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COMP HOXD10 ASTN1 GPRC5B PLCE1	1.30e-04	175	124	5	84d252f3e432231687613299bbea14978bb4b06b
ToppCell	P15-Endothelial-lymphatic_endothelial_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COMP HOXD10 ASTN1 GPRC5B PLCE1	1.30e-04	175	124	5	a00c6fa9b33640710dd05a3799031147196f0986
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GRK5 PKNOX2 KCNH1 NAV3 RORB	1.37e-04	177	124	5	9ec7f1e64312d26d434b3312b58386715dbad644
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ATP13A4 CDKL2 NMNAT3 PIK3CB MAML2	1.37e-04	177	124	5	da8802a6351d3e510822f82e2fde8a4314a2216e
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GRK5 PKNOX2 KCNH1 NAV3 RORB	1.37e-04	177	124	5	016277dfd59b1793fddaaadc2b3f41622d76ce3a
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	GABRG3 SLC52A3 ST8SIA6 NAV3 PKNOX1	1.41e-04	178	124	5	be4976bbfd9ebbc568155ede99a07670c43aa372
ToppCell	cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FLNC CDKL2 PKNOX2 TSC22D1 PALLD	1.41e-04	178	124	5	8ec2a25dda96c9cc9c2904b6cb18f75a293f4969
ToppCell	cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FLNC CDKL2 PKNOX2 TSC22D1 PALLD	1.41e-04	178	124	5	6c91331196696e0cf239d105f458e3230659fa38
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	GABRG3 SLC52A3 ST8SIA6 NAV3 PKNOX1	1.41e-04	178	124	5	91bf3c7c05d2e67ee590389a1b36c517d0ed7ebf
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ATP13A4 ACACA COMP ADGRV1 OCLN	1.41e-04	178	124	5	f5ed4a6e3eb8056b1be1fb311021710c95bdf888
ToppCell	Control-Epithelial_cells-AT2\|Control / group, cell type (main and fine annotations)	ACACA TOX CDKL2 ADGRV1 BTBD9	1.49e-04	180	124	5	198b19e7910b4a8cc7e820c525ab357c7f99f578
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CDKL2 NMNAT3 CFAP61 SPAG17 NFAT5	1.52e-04	181	124	5	6a6bd8e020cb0929b6ecdcb55d467ad24fecfaf0
Drug	irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A	NCOA2 HIVEP2 ARFGEF1 STAM PIK3CB SEC24B NCOA1 KAT6B	4.25e-06	171	123	8	7535_DN
Drug	Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A	ARFGEF1 UPF1 RSBN1 PIK3CB NUP210 KAT6B NFAT5 PALLD	8.53e-06	188	123	8	4845_DN
Drug	Clotrimazole [23593-75-1]; Down 200; 11.6uM; MCF7; HT_HG-U133A	NCOA2 ARFGEF1 KRR1 VPS13D MARCHF3 NFYA PKNOX1 KAT6B	9.95e-06	192	123	8	6207_DN
Drug	S-adenosyl-D-homocysteine	NCOA2 ERCC3 COQ3 SLC40A1 RPH3A KMT2C SETDB1 GTF2F1	2.84e-05	222	123	8	CID000000193
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	NCOA2 HIVEP2 WT1 SETDB1 NAV3 SMG9 KAT6B	4.23e-05	172	123	7	6439_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 NAGLU SETDB1 THBS3 PKNOX1 SMG9 KAT6B	4.39e-05	173	123	7	3243_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	NCOA2 WT1 SETDB1 NAV3 PKNOX1 SMG9 KAT6B	4.55e-05	174	123	7	5745_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	NCOA2 HIVEP2 WT1 SETDB1 PKNOX1 SMG9 KAT6B	4.72e-05	175	123	7	6736_DN
Drug	Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; PC3; HT_HG-U133A	TNIK HIVEP2 GRK5 ARFGEF1 NUP210 NFYA NCOA1	5.07e-05	177	123	7	4652_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	NCOA2 HIVEP2 WT1 KDM3B PKNOX1 SMG9 KAT6B	5.45e-05	179	123	7	6609_DN
Drug	Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A	UPF1 CLOCK VPS13D NFYA PKNOX1 NCOA1 NFAT5	7.93e-05	190	123	7	2619_DN
Drug	Cotinine (-) [486-56-6]; Down 200; 22.6uM; PC3; HG-U133A	HIVEP2 GART KRR1 DSN1 LACTB2 R3HDM1 OGA	8.47e-05	192	123	7	1929_DN
Drug	(1Z)-2-methylbutanal oxime	WT1 KCNH1	8.65e-05	3	123	2	CID005362772
Drug	AC1L1S5D	WT1 KCNH1	8.65e-05	3	123	2	CID000009023
Drug	Glibenclamide [10238-21-8]; Down 200; 8uM; HL60; HG-U133A	ACACA RIPK2 ARFGEF1 NUP210 RBM14 SMG9 GOLGA3	8.75e-05	193	123	7	1546_DN
Drug	Delcorine; Down 200; 8.4uM; MCF7; HT_HG-U133A	NCOA2 HIVEP2 ERCC6 MAML1 THBS3 VPS13D TAF5L	9.33e-05	195	123	7	4737_DN
Drug	Cephalothin sodium salt [58-71-9]; Down 200; 9.6uM; HL60; HT_HG-U133A	NCOA2 GART WT1 LAMC1 VPS13D NFYA NFAT5	9.33e-05	195	123	7	2517_DN
Drug	Tiapride hydrochloride [51012-33-0]; Down 200; 11uM; PC3; HT_HG-U133A	EPPK1 SETDB1 MARCHF3 PKNOX1 NCOA1 PLCE1 UEVLD	9.33e-05	195	123	7	7362_DN
Drug	Lobeline alpha (-) hydrochoride [134-63-4]; Down 200; 10.6uM; HL60; HG-U133A	ACACA ARFGEF1 NFYA SMG9 NUP188 OGA GOLGA3	9.63e-05	196	123	7	1770_DN
Drug	Clorsulon [60200-06-8]; Down 200; 10.6uM; HL60; HG-U133A	ERCC6 GRK5 C11orf24 VPS13D RBM14 NCOA1 TAF5L	9.63e-05	196	123	7	1735_DN
Drug	Budesonide [51333-22-3]; Down 200; 9.2uM; PC3; HT_HG-U133A	NCOA2 EPPK1 HIVEP2 KDM3B SETDB1 NUP210 NFYA	9.63e-05	196	123	7	6330_DN
Drug	Carbamazepine [298-46-4]; Down 200; 17uM; MCF7; HT_HG-U133A	FLNB GRK5 GART C11orf24 NUP210 SMG9 GPRC5B	9.94e-05	197	123	7	5518_DN
Drug	Torsemide [56211-40-6]; Up 200; 11.4uM; PC3; HT_HG-U133A	GRK5 WT1 THBS3 NUP210 PKNOX1 NUP188 R3HDM1	9.94e-05	197	123	7	5057_UP
Drug	Ketoprofen [22071-15-4]; Down 200; 15.8uM; HL60; HT_HG-U133A	NAGLU RIPK2 MAML1 SETDB1 PIK3CB MARCHF3 NCOA1	9.94e-05	197	123	7	2354_DN
Drug	Epirizole [18694-40-1]; Down 200; 17uM; HL60; HT_HG-U133A	FLNB ARFGEF1 C11orf24 UPF1 VPS13D OGA UEVLD	9.94e-05	197	123	7	1845_DN
Drug	Naringenine [480-41-1]; Down 200; 14.6uM; HL60; HT_HG-U133A	FLNB MAML1 POMGNT1 VPS13D PKNOX1 NCOA1 OGA	9.94e-05	197	123	7	1342_DN
Drug	Alverine citrate salt [5560-59-8]; Down 200; 8.4uM; HL60; HG-U133A	GART C11orf24 UPF1 KRR1 ZZEF1 NUP210 R3HDM1	1.03e-04	198	123	7	1426_DN
Drug	Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; HL60; HT_HG-U133A	MAML1 C11orf24 UPF1 SETDB1 NFYA NCOA1 NFAT5	1.03e-04	198	123	7	2362_DN
Drug	Midecamycin [35457-80-8]; Down 200; 5uM; MCF7; HT_HG-U133A	GART C11orf24 VPS13D MARCHF3 NUP210 PKNOX1 TAF5L	1.03e-04	198	123	7	5345_DN
Drug	Cefalonium [5575-21-3]; Down 200; 8.8uM; HL60; HT_HG-U133A	RIPK2 POMGNT1 CLOCK SETDB1 LACTB2 NUP210 NFAT5	1.06e-04	199	123	7	2921_DN
Drug	Cefoperazone dihydrate; Down 200; 5.8uM; HL60; HG-U133A	ACACA GART WT1 RSBN1 TSC22D1 GTF2F1 RBM14	1.06e-04	199	123	7	1627_DN
Disease	myofibrillar myopathy 5 (implicated_via_orthology)	FLNB FLNC	4.91e-05	3	120	2	DOID:0080096 (implicated_via_orthology)
Disease	distal muscular dystrophy 4 (implicated_via_orthology)	FLNB FLNC	4.91e-05	3	120	2	DOID:0111190 (implicated_via_orthology)
Disease	hematocrit	HIVEP2 ACACA WT1 R3HDM2 ADGRV1 SLC40A1 THBS3 ACAD11 HOXD10 KCNH1 SMG9 ASXL2 MAML2 NFAT5	6.46e-05	1011	120	14	EFO_0004348
Disease	Renal glomerular disease	WT1 LMX1B PLCE1	1.09e-04	23	120	3	C0268731
Disease	Glomerulopathy Assessment	WT1 LMX1B PLCE1	1.09e-04	23	120	3	C4521256
Disease	sleep duration	TNIK ATPSCKMT KDM3B BTBD9 PKNOX2 TBCK SLC2A11 GPRC5B	1.21e-04	362	120	8	EFO_0005271
Disease	stimulant use measurement	NCOA2 ATP13A4 EYS	2.00e-04	28	120	3	EFO_0600076
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Positive	TNIK R3HDM2 BEND2 MAML2 KAT6B	2.02e-04	131	120	5	C4704862
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Negative	TNIK R3HDM2 BEND2 MAML2 KAT6B	2.02e-04	131	120	5	C4552091
Disease	Juvenile arthritis	TNIK R3HDM2 BEND2 MAML2 KAT6B	2.02e-04	131	120	5	C3495559
Disease	Juvenile psoriatic arthritis	TNIK R3HDM2 BEND2 MAML2 KAT6B	2.02e-04	131	120	5	C3714758
Disease	Juvenile-Onset Still Disease	TNIK R3HDM2 BEND2 MAML2 KAT6B	2.33e-04	135	120	5	C0087031
Disease	Cockayne syndrome (implicated_via_orthology)	ERCC3 ERCC6	2.43e-04	6	120	2	DOID:2962 (implicated_via_orthology)
Disease	cancer antigen 15.3 measurement	MSTO1 THBS3	3.40e-04	7	120	2	EFO_0010585
Disease	restless legs syndrome (implicated_via_orthology)	BTBD9 PKNOX2	4.52e-04	8	120	2	DOID:0050425 (implicated_via_orthology)
Disease	prostate cancer (is_marker_for)	NCOA2 KMT2C SETDB1 PIK3CB NCOA1	4.53e-04	156	120	5	DOID:10283 (is_marker_for)
Disease	colorectal cancer (is_marker_for)	ERCC3 ERCC6 KDM3B DSN1 PIK3CB	4.66e-04	157	120	5	DOID:9256 (is_marker_for)
Disease	Proteinuria	MUC16 NCK1 LMX1B	7.19e-04	43	120	3	C0033687
Disease	thiamine measurement	ANO5 MAML2	7.23e-04	10	120	2	EFO_0010540
Disease	Hereditary Nephrotic Syndromes, Autosomal Dominant	WT1 LMX1B	8.81e-04	11	120	2	cv:CN043612
Disease	IGF-1 measurement	EIF3E R3HDM2 NCK1 BTBD9 STARD9 ASTN1 ASXL2 CFAP61	8.83e-04	488	120	8	EFO_0004627
Disease	lymphocyte count	TNIK NCOA2 FLNB MED30 EPPK1 ACACA GRK5 NCK1 RPH3A RSBN1 NFATC2 SMG9 ADGRE1 GOLGA3 PLCE1	8.95e-04	1464	120	15	EFO_0004587
Disease	cleft palate (is_implicated_in)	FLNB NECTIN1	1.05e-03	12	120	2	DOID:674 (is_implicated_in)
Disease	coronary artery disease	HIVEP2 WT1 RNF213 LAMC1 R3HDM2 CLOCK RPH3A RSBN1 ACAD11 NUP210 NFAT5 PALLD PLCE1	1.16e-03	1194	120	13	EFO_0001645
Disease	serum urea measurement	R3HDM2 MSTO1 THBS3 NFAT5 PLCE1	1.23e-03	195	120	5	EFO_0009795
Disease	Familial idiopathic steroid-resistant nephrotic syndrome	WT1 LMX1B	1.24e-03	13	120	2	cv:C4273714
Disease	glucose metabolism measurement, age-related hearing impairment	TOX NFATC2 NAV3	1.25e-03	52	120	3	EFO_0005782, EFO_0009367
Disease	retinal vasculature measurement	EIF3E LAMC1 EYS MUC17 NAV3 R3HDM1 PALLD PLCE1	1.28e-03	517	120	8	EFO_0010554
Disease	Autosomal recessive limb-girdle muscular dystrophy	POMGNT1 ANO5	1.45e-03	14	120	2	cv:C2931907
Disease	insulin metabolic clearance rate measurement, glucose homeostasis measurement	ZZEF1 ST8SIA6	1.45e-03	14	120	2	EFO_0006830, EFO_0006896
Disease	Malignant neoplasm of breast	NCOA2 FLNB ERCC3 ERCC6 MTMR8 WT1 THBS3 PIK3CB KCNH1 NCOA1 OCLN KAT6B	1.45e-03	1074	120	12	C0006142
Disease	caffeine measurement	LAMC1 MAML2	1.66e-03	15	120	2	EFO_0021177
Disease	body weight	GABRG3 HIVEP2 HDX RIPK2 ANO5 ADGRV1 ZZEF1 RPH3A EYS NFATC2 LMX1B KAT6B GPRC5B	1.89e-03	1261	120	13	EFO_0004338
Disease	Seizures	KDM3B PLPPR1 GTF3C3 GLDC TBCK	2.01e-03	218	120	5	C0036572
Disease	Colorectal Carcinoma	FLNC ERCC6 ACACA ARFGEF1 LAMC1 STAM KMT2C PKNOX1 SPAG17	2.33e-03	702	120	9	C0009402
Disease	polychlorinated biphenyls measurement	LACTB2 GLDC PALLD	2.38e-03	65	120	3	EFO_0007042
Disease	Intellectual Disability	HIVEP2 NAGLU KDM3B GTF3C3 KMT2C ASTN1 PYCR2	2.40e-03	447	120	7	C3714756
Disease	migraine disorder, systolic blood pressure	RNF213 PLCE1	2.40e-03	18	120	2	EFO_0006335, MONDO_0005277
Disease	lung non-small cell carcinoma (is_implicated_in)	NCOA2 ERCC3 ERCC6 KMT2C	2.54e-03	139	120	4	DOID:3908 (is_implicated_in)
Disease	Neoplastic Cell Transformation	CDKL2 SLC40A1 TSC22D1 OCLN	2.54e-03	139	120	4	C0007621
Disease	blood urea nitrogen measurement	R3HDM2 NCK1 ADGRV1 THBS3 ASXL2 NFAT5 PLCE1	2.55e-03	452	120	7	EFO_0004741
Disease	osteochondrodysplasia (is_implicated_in)	FLNB COMP	2.68e-03	19	120	2	DOID:2256 (is_implicated_in)
Disease	acute lymphoblastic leukemia, response to antineoplastic agent	ST8SIA6 MAML2	2.68e-03	19	120	2	EFO_0000220, GO_0097327
Disease	schizophrenia (implicated_via_orthology)	HIVEP2 KIF3B ASTN1	2.71e-03	68	120	3	DOID:5419 (implicated_via_orthology)
Disease	Osteoarthritis of hip	COMP LMX1B	2.97e-03	20	120	2	C0029410
Disease	prostate adenocarcinoma (is_implicated_in)	NCOA2 PIK3CB	2.97e-03	20	120	2	DOID:2526 (is_implicated_in)
Disease	aspartate aminotransferase to alanine aminotransferase ratio	EPPK1 NCK1 STAM COQ3 ST8SIA6	2.99e-03	239	120	5	EFO_0010934
Disease	pentachlorophenol measurement	MUC16 PLPPR1 EYS	3.32e-03	73	120	3	EFO_0022071
Disease	parathion measurement	MUC16 PLPPR1 EYS	3.32e-03	73	120	3	EFO_0022070
Disease	potassium chromate measurement	MUC16 PLPPR1 EYS	3.32e-03	73	120	3	EFO_0022072
Disease	mercuric chloride measurement	MUC16 PLPPR1 EYS	3.32e-03	73	120	3	EFO_0022068
Disease	heptachlor epoxide measurement	MUC16 PLPPR1 EYS	3.32e-03	73	120	3	EFO_0022067
Disease	methoxychlor measurement	MUC16 PLPPR1 EYS	3.32e-03	73	120	3	EFO_0022069
Disease	4,6-dinitro-o-cresol measurement	MUC16 PLPPR1 EYS	3.32e-03	73	120	3	EFO_0022053
Disease	2,4,5-trichlorophenol measurement	MUC16 PLPPR1 EYS	3.32e-03	73	120	3	EFO_0022052
Disease	azinphos methyl measurement	MUC16 PLPPR1 EYS	3.32e-03	73	120	3	EFO_0022055
Disease	aldrin measurement	MUC16 PLPPR1 EYS	3.32e-03	73	120	3	EFO_0022054
Disease	dicofol measurement	MUC16 PLPPR1 EYS	3.32e-03	73	120	3	EFO_0022060
Disease	disulfoton measurement	MUC16 PLPPR1 EYS	3.32e-03	73	120	3	EFO_0022062
Disease	dieldrin measurement	MUC16 PLPPR1 EYS	3.32e-03	73	120	3	EFO_0022061
Disease	endrin measurement	MUC16 PLPPR1 EYS	3.32e-03	73	120	3	EFO_0022064
Disease	endosulfan measurement	MUC16 PLPPR1 EYS	3.32e-03	73	120	3	EFO_0022063
Disease	heptachlor measurement	MUC16 PLPPR1 EYS	3.32e-03	73	120	3	EFO_0022066
Disease	ethion measurement	MUC16 PLPPR1 EYS	3.32e-03	73	120	3	EFO_0022065
Disease	chlorpyrifos measurement	MUC16 PLPPR1 EYS	3.32e-03	73	120	3	EFO_0022057
Disease	cadmium chloride measurement	MUC16 PLPPR1 EYS	3.32e-03	73	120	3	EFO_0022056
Disease	diazinon measurement	MUC16 PLPPR1 EYS	3.32e-03	73	120	3	EFO_0022059
Disease	dibutyl phthalate measurement	MUC16 PLPPR1 EYS	3.32e-03	73	120	3	EFO_0022058
Disease	environmental exposure measurement	MUC16 PLPPR1 EYS	3.32e-03	73	120	3	EFO_0008360
Disease	DDT metabolite measurement	MUC16 PLPPR1 EYS	3.45e-03	74	120	3	EFO_0007886
Disease	visceral adipose tissue measurement	ARPP21 HIVEP2 NAGLU RIPK2 ZZEF1 NFAT5 GOLGA3	3.59e-03	481	120	7	EFO_0004765
Disease	colorectal carcinoma (is_implicated_in)	NCOA2 ERCC6	3.59e-03	22	120	2	DOID:0080199 (is_implicated_in)
Disease	Down syndrome (is_marker_for)	ERCC3 GART	3.59e-03	22	120	2	DOID:14250 (is_marker_for)
Disease	RS-6-hydroxywarfarin measurement	GABRG3 ATP13A4 TOX TSC22D1	3.75e-03	155	120	4	EFO_0803328
Disease	Prostatic Neoplasms	NCOA2 NAGLU LAMC1 KMT2C SETDB1 PIK3CB UCP3 NCOA1	3.75e-03	616	120	8	C0033578
Disease	Malignant neoplasm of prostate	NCOA2 NAGLU LAMC1 KMT2C SETDB1 PIK3CB UCP3 NCOA1	3.75e-03	616	120	8	C0376358
Disease	Disproportionate short stature	FLNB COMP ANO5	3.85e-03	77	120	3	C0878659

Protein segments in the cluster

Peptide	Gene	Start	Entry
QMAQPNYGLELVTGS	CFAP61	1066	Q8NHU2
QPMTGYVNNSLSVFL	ANO5	771	Q75V66
TTLIGVTMNLNGAYP	ATP13A4	941	Q4VNC1
GIQYLQEQGMLGTTP	ARFGEF1	716	Q9Y6D6
VQTMNSDPGLAVGYT	COMP	561	P49747
SNGLSVQTVVGMLYN	COQ3	296	Q9NZJ6
GAINVTYTTVPGMLS	ADGRV1	2856	Q8WXG9
TRQSPNSYVVIMNGS	ACACA	686	Q13085
ITMGGYSNASPVQVK	ERCC6	711	Q03468
NNQQGTPVQSVMVSY	ARPP21	706	Q9UBL0
GMVNFSEVSGYPVLQ	ASTN1	801	O14525
TQIGPSYRGMINVST	ASXL2	1321	Q76L83
INQGSYSENSGIPSM	ACAD11	271	Q709F0
TGMAPEGISQNEVVY	NAGLU	441	P54802
STVVLQSPQQSGYIM	R3HDM1	571	Q15032
SSMGGQMQGLVVQYT	R3HDM2	591	Q9Y2K5
PNGNATYVMTTQGPV	RAI2	106	Q9Y5P3
PMAGSYGAQPVVQTQ	RBM14	456	Q96PK6
IVYIMGVNPTAQSSG	OCLN	191	Q16625
SQIYGRSQTVAMQGP	KAT6B	1941	Q8WYB5
LVVLQMPYGSGEQNA	OVOS1	776	Q6IE37
TGTQMPIYVTGITNH	NUP210	1181	Q8TEM1
LYGMASGITQIVAQP	MAML1	756	Q92585
VSTMQQFYGIPVTGV	MMP24	111	Q9Y5R2
MYPSTNIAVTNVGTT	MUC16	6586	Q8WXI7
YGGQQMILTGQNFTS	NFATC2	591	Q13469
FPFMGQVVTGTQNSE	KMT2C	3126	Q8NEZ4
NYGNSSVQASEMTVP	HDX	196	Q7Z353
YILVSMLGPNDGNQS	MAGEB4	176	O15481
QYGITMGPTEVLNQE	EYS	1706	Q5T1H1
YVTVMQNNPLTSGLE	NCK1	246	P16333
QYVTVGSGVVNIVMT	SLC2A7	321	Q6PXP3
ISQTNPGSQFMYVVD	MTMR8	226	Q96EF0
NVGAGSYLEINIPMT	KIAA1109	411	Q2LD37
QMSYGSGSVTQAGVQ	BEND2	76	Q8NDZ0
TPTQQGNMQVLVTYG	FLNB	911	O75369
MTLQGTNTYLVGTGP	LACTB2	26	Q53H82
VPQSIANSLMGNGYI	OR14J1	76	Q9UGF5
AQYLQQQQPGVMSSS	MSTO1	451	Q9BUK6
YIIGTMNQGVSSSPN	NAV3	2151	Q8IVL0
QQGNMAVTVTYGGDP	FLNC	936	Q14315
TQIIPGTALYNIGDM	KDM3B	1096	Q7LBC6
QLAMDIGTPYQFNGS	KCNH1	421	O95259
CYIMVQGNTVSAIGP	KRR1	181	Q13601
VMGVQQGEVLGSSPY	PELP1	556	Q8IZL8
VGTQDTPYMVNGQEI	GOLGA3	336	Q08378
FQQVSQIQSGVSPGM	NFAT5	831	O94916
RNMQLPNGVTYHTGT	MED30	56	Q96HR3
LNVYSQPGFTVSGML	POU3F4	131	P49335
YQPTEMAVVLNGGTI	GPRC5B	376	Q9NZH0
GNYTIMAANPQGRIS	PALLD	1071	Q8WX93
RNVGNMQPTAQYSGG	MAML2	806	Q8IZL2
SQGALTQGYISMSQP	UPF1	1061	Q92900
INSGMGTETIPIQGY	CDKL2	426	Q92772
VGVNAGVSMNIQPMY	SLC2A11	131	Q9BYW1
DIYVNSIGPVSSINM	GABRG3	76	Q99928
PMTYLGSSQNEVLNT	DSN1	256	Q9H410
YNNSPEGSSTVMLQL	HOXD10	166	P28358
VVMGNNAVSPYQQVI	EIF3E	391	P60228
GSLVNGQPQYVMQVS	MARCHF3	31	Q86UD3
GQPQYVMQVSAKDGQ	MARCHF3	36	Q86UD3
VTTSTGNQALYGGQM	KLF18	476	A0A0U1RQI7
TGNQALYGGQMTTST	KLF18	676	A0A0U1RQI7
QTMLAGVQYPSSINL	LAMC1	121	P11047
AQGPTVTMTTNELYQ	EMILIN2	301	Q9BXX0
YGPTSQGERMQILQN	ERCC3	581	P19447
VGTVGYMAPEVLNNQ	GRK5	346	P34947
LGSGAIVVQLAQPYM	BTBD9	466	Q96Q07
GQYVDVPMTSQQQAV	C4orf54	1641	D6RIA3
TYGQMFTSQNAPTVR	SEC24B	206	O95487
QVVSGGALYQPVTMV	PKNOX2	236	Q96KN3
GALYQPVTMVTSQGQ	PKNOX2	241	Q96KN3
QGQTIMQVPVSGTQG	NFYA	86	P23511
QTFTEQMNIVYSGIP	MUC17	4216	Q685J3
NLGMQEYRVPQGVQT	RSBN1	321	Q5VWQ0
MAALGPSSQNVTEYV	GTF2F1	1	P35269
VGVYTGQMSNVLSVQ	TAF5L	556	O75529
VSLMYSTQQGGLIVG	RPH3A	556	Q9Y2J0
NALTNGMLPSVQTYS	SLC52A3	311	Q9NQ40
TVYQEPIMSQGAALS	OGA	431	O60502
VAMATVAGGTVYQPV	PKNOX1	201	P55347
MDPAVYSLTIVSGQN	PLCE1	1866	Q9P212
RSYSNIPVTSLQGMN	NCOA1	531	Q15788
QGVSPQMITVFIDGY	POMGNT1	326	Q8WZA1
TDPYTGQQISLFQAM	EPPK1	2311	P58107
TDPYTGQQISLFQAM	EPPK1	4446	P58107
VYQIQNRGMGTAAPA	SMG9	146	Q9H0W8
VSQNNTPVGTNMSYE	ST8SIA6	141	P61647
YMSNGSNSANIVPET	SLC40A1	431	Q9NP59
MTNTPVVVQEGATVY	PYCR2	121	Q96C36
YVQQQPILQTAMSSG	TSC22D1	656	Q15714
MGPYVQGLSQHVVTN	STARD9	181	Q9P2P6
QSGALVRMQGVPYTA	ESRP2	671	Q9H6T0
MGTVQTNPYTENATA	PIK3CB	476	P42338
MAVGNNTQRSYSIIP	PLPPR1	1	Q8TBJ4
GYNMGNIPTQISGSN	SPAG17	1021	Q6Q759
NMGAVRSKGPVVQYT	SETDB1	421	Q15047
IYQSSGNTGMAQTLL	GTF3C3	866	Q9Y5Q9
FSQYSNVVIFGVPQM	ATPSCKMT	151	Q6P4H8
VISASVQPQGYGMHN	ADGRE1	726	Q14246
MGQVVTAYPTFATQQ	CLOCK	731	O15516
QGQYMVVTTEPLTQA	C11orf24	381	Q96F05
SGMQATTPQGSNYAL	NCOA2	451	Q15596
ATTMYSPGGVSQVVQ	SPG11	1086	Q96JI7
STAGGDPNMQLNVYT	RNF213	5036	Q63HN8
SPYNGLVAGLQRQMS	UCP3	76	P55916
TGAPGSNEQYNVGMV	TNIK	866	Q9UKE5
TVMVANVGPASYNVE	KIF3B	311	O15066
DVTNPLQIMYSVSQG	RIPK2	231	O43353
TVYQQGVGYVPITGM	TOLLIP	191	Q9H0E2
YSSFNNGQLAPGITM	RORB	206	Q92753
GGYQPIFTMSAQQSQ	PIEZO2	2446	Q9H5I5
QGSGKMQYFQPTIQE	XRN1	1241	Q8IZH2
PMGQQGSLGEQQYSV	WT1	181	P19544
LLMNSEQPQGEYGVT	NUP188	666	Q5SRE5
TQAAYPNTMVSSVQG	STAM	456	Q92783
GELTQGPYTAMLQNF	TBCK	826	Q8TEA7
VQTMNSDPGLAVGYT	THBS3	756	P49746
QRTVDGMQQEGTPYT	GART	256	P22102
TGTIPVMYQGNTYNI	UEVLD	56	Q8IX04
SYMPQQVTVAVGRNA	ZZEF1	311	O43149
GSVMYTSISQILGQN	HIVEP2	1346	P31629
TMQQGFTLQPDYQTI	TOX	461	O94900
YLGTSGIQPVQNMAI	TM7SF3	111	Q9NS93
ISGYPATQSMTQAVI	USF1	81	P22415
NQLIGTTQPFMLYVT	VPS13D	3881	Q5THJ4
NLAAIMITYPSTNGV	GLDC	691	P23378
QQQIVAMEQSPYGSS	LMX1B	316	O60663
QNVAIYNPSMGVSVL	NECTIN1	76	Q15223
TGMYQVIQGIISPVN	NMNAT3	36	Q96T66